GlassScriptPhysician profile
Deepti Sharma
NPI 1659735173
$1,920.28
in general payments reported to CMS, 2019-2025
18 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $42.01 · 2022: $217 · 2023: $768 · 2024: $567 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,536.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $424.16 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $368.95 | 2023-2024 | Ubrelvy, Qulipta, Vraylar |
| Astrazeneca Pharmaceuticals LP | $322.79 | 2022-2024 | Breztri, Airsupra |
| Lilly USA, LLC | $190.00 | 2022-2023 | Mounjaro, Jardiance |
| Novo Nordisk INC | $111.85 | 2019-2023 | Rybelsus, Ozempic, Saxenda |
| Amgen INC. | $109.95 | 2019 | |
| Abbott Laboratories | $78.66 | 2022-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Pfizer INC. | $68.68 | 2023 | |
| Dexcom, INC. | $42.01 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.00 | 2022-2023 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.55 | 2023 | Xifaxan |
| Corium, LLC | $25.27 | 2023 | Adlarity |
| Esperion Therapeutics, INC. | $21.88 | 2023 | Nexletol |
| Inari Medical, INC. | $20.33 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Axsome Therapeutics, INC. | $19.86 | 2023 | Auvelity |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $16.21 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.75 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepti Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.